Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine in mosquito-bite allergy
NCT00258141Phase 4Unknown
- Sponsor
- Uriach
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rupatadine in Hypersensitivity To Mosquito Bites (HMB), sponsored by Uriach. Status: unknown.
02
Drugs
rupatadine
03
Conditions
Hypersensitivity To Mosquito Bites (HMB)
Beyond the preview
Go deeper on NCT00258141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258141.